During the past decade, Piedmont Heart Institute conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 25 clinical trials were completed, i.e. on average, 37.9% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 16 clinical trials were completed. i.e. 48.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Piedmont Heart Institute" #1 sponsor was "Abbott Medical Devices" with 14 trials, followed by "Edwards Lifesciences" with 6 trials sponsored, "Piedmont Healthcare" with 6 trials sponsored, "Medtronic Vascular" with 5 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Heart Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "LivaNova" with 2 trials as a collaborator and "Medpace, Inc." with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Heart Institute" are "Heart Failure" (16 trials), "Cardiovascular Diseases" (10 trials), "Coronary Artery Disease" (9 trials), "Hypertension" (6 trials) and "Mitral Regurgitation" (6 trials). Many other conditions were trialed in "Piedmont Heart Institute" in a lesser frequency.

Most popular intervention types in "Piedmont Heart Institute" are "Device" (69 trials), "Drug" (14 trials), "Other" (6 trials), "Procedure" (5 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (3 trials), "Experimental" (2 trials), "HeartMate 3 LVAS" (2 trials), "Placebo" (2 trials) and "Renal Denervation (Symplicity Spyral™)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Heart Institute" are 86 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Heart Institute". undefined are not yet recruiting, 25 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in Piedmont Heart Institute, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 59 trials that are defined as “Not Applicable".